Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial

OBJECTIVE: To assess efficacy and safety of fulranumab, a fully human monoclonal antibody against nerve growth factor, in patients with diabetic peripheral neuropathic pain (DPNP). METHODS: In this phase II, double-blind, placebo-controlled trial, patients with moderate to severe DPNP were randomize...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wang, Hao, Romano, Gary, Frustaci, Mary Ellen, Bohidar, Norm, Ma, Huizhong, Sanga, Panna, Ness, Seth, Russell, Lucille J., Fedgchin, Margaret, Kelly, Kathleen M., Thipphawong, John
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams & Wilkins 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141990/
https://ncbi.nlm.nih.gov/pubmed/25008392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000686
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge